Related Experiment Video
Updated: Apr 28, 2026

Improving IV Insulin Administration in a Community Hospital
Published on: June 11, 2012
Glycemic control in critically ill: A moving target
1Director, Critical Care and Emergency Medicine, AMRI Hospitals, P4 & 5, CIT Scheme - LXXII, Block- A, Gariahat Road, Kolkatta, West Bengal, India.
Insights
Effective glycemic control in intensive care units (ICUs) requires avoiding hyperglycemia and hypoglycemia. Glycemic variability also poses risks, necessitating protocols that manage all three domains for better patient outcomes.
Area of Science:
- Critical Care Medicine
- Endocrinology
- Metabolic Disorders
Background:
- Glycemic control in intensive care units (ICUs) is complex, involving multiple patient factors.
- Hyperglycemia, hypoglycemia, and glycemic variability present distinct challenges in critically ill patients.
Purpose of the Study:
- To outline the key domains of glycemic control in ICUs.
- To discuss the implications of patient population and diabetic status on glycemic targets.
- To highlight the detrimental effects of hypoglycemia and glycemic variability.
Main Methods:
- Review of existing literature on glycemic control in ICUs.
- Analysis of patient populations, including surgical and medically ill patients.
- Consideration of diabetic status and its influence on glycemic tolerance.
Main Results:
- Excessive hyperglycemia should be avoided, with upper limits varying by patient type and diabetic status.
- Hypoglycemia is detrimental across all critically ill patient groups and must be prevented.
- Glycemic variability is increasingly recognized as harmful and requires targeted reduction.
Conclusions:
- Glycemic control protocols must address hyperglycemia, hypoglycemia, and variability.
- Patient-specific factors influence optimal glycemic targets.
- Emerging technologies like continuous glucose monitoring can aid in managing these three domains.
Abstract:
Glycemic control targets in intensive care units (ICUs) have three distinct domains. Firstly, excessive hyperglycemia needs to be avoided. The upper limit of this varies depending on the patient population studied and diabetic status of the patients. Surgical patients particularly cardiac surgery patients tend to benefit from a lower upper limit of glycemic control, which is not evident in medically ill patient. Patient with premorbid diabetic status tends to tolerate higher blood sugar level better than normoglycemics. Secondly, hypoglycemia is clearly detrimental in all groups of critically ill patient and all measures to avoid this catastrophe need to be a part of any glycemic control protocol. Thirdly, glycemic variability has increasingly been shown to be detrimental in this patient population. Glycemic control protocols need to take this into consideration and target to reduce any of the available metrics of glycemic variability. Newer technologies including continuous glucose monitoring techniques will help in titrating all these three domains within a desirable range.
More Related Videos
07:35Author Spotlight: Investigating the Blood Glucose Homeostasis in Murine Brain Using a Cost-Effective Hyperglycemic And Hypoglycemic Clamp Technique
Published on: January 26, 2024
09:17Use of a Central Venous Line for Fluids, Drugs and Nutrient Administration in a Mouse Model of Critical Illness
Published on: May 2, 2017
Related Concept Videos
Hypoglycemia and Glucagon
Diabetes: Management and Pharmacotherapy
Insulin remains the cornerstone of treatment for most patients with type 1 and many...
Acute Pancreatitis II: Clinical Manifestations and Management
Hyperglycemia
Hypoglycemia
Oral Hypoglycemic Agents: α-Glucosidase Inhibitors
Acarbose and miglitol are...